Patent · US Active

Fc receptor binding proteins

US8815246B2 · kind B2 · utility

15Cited by

5References

12Claims

0Family size

Assignees

Dyax Corp. · US
Syntonix Pharmaceuticals, Inc. · US

Inventors

Christopher TenHoor · Hopkinton, US
Arumugam Muruganandam · Bengaluru, IN
Robert Charles Ladner · Urbana, US
Clive Wood · Boston, US
Alan J. Bitonti · Acton, US
James Stattel · Hagerstown, US
Kevin McDonnell · Lexington, US
Liming Liu · Whitemarsh, US
Jennifer A. Dumont · Groton, US
Aaron Sato · Somerville, US
Malini Viswanathan · Acton, US

Key dates

Filing date	Sep 14, 2012
Grant date	Aug 26, 2014
Priority date	—
Expiry date	Sep 14, 2032

Classification

Technology area (CPC G)Physics
CPC primaryG01N2333/70535
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

This disclosure provides, inter alia, proteins that bind to FcRn, e.g., immunoglobulins that inhibit FcRn with high affinity and selectivity. The FcRn-binding proteins can be used to treat a variety of disorders including autoimmune disorders.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.